BioAtla, Inc. (BCAB) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bioatla, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.096 Good day, everyone, and welcome to today's BioATLA third quarter 2025 00:00:05.096 -- 00:00:10.341 earnings call. This time, all participants are in a listen-only 00:00:10.341 -- 00:00:15.405 mode. Later, you may have the opportunity to ask questions during 00:00:15.405 -- 00:00:18.468 the question and answer session. 00:00:18.468 -- 00:00:22.171 I will be standing by should you need any assistance. 00:00:22.171 -- 00:00:28.397 It is now my pleasure to turn the conference over to Julie Miller with LifeSci Advisors. 00:00:28.397 -- 00:00:30.798 Please go ahead. 00:00:31.655 -- 00:00:34.618 Thank you, Operator, and good afternoon, everyone. 00:00:34.618 -- 00:00:38.202 With me today on the phone from BioATLA are Dr. 00:00:38.202 -- 00:00:42.026 Jay Short, Chairman, CEO, and Co-Founder, Dr. 00:00:42.026 -- 00:00:47.411 Eric Sievers, Chief Medical Officer, Sherry Lydic, Chief Commercial Officer, 00:00:47.411 -- 00:00:51.035 and Richard Waldron, Chief Financial Officer. 00:00:51.035 -- 00:00:55.860 Earlier this afternoon, BioATLA released financial results and a business update for 00:00:55.860 -- 00:00:59.481 the quarter ended September 30th, 2025. 00:00:59.498 -- 00:01:04.146 A copy of the press release is available on the company's website. 00:01:04.146 -- 00:01:09.115 Before we begin, I'd like to remind everyone that statements made during this conference 00:01:09.115 -- 00:01:14.405 call will include forward-looking statements, including but not limited to statements 00:01:14.405 -- 00:01:19.634 regarding BioAtlas business plans and prospects, potential selective licensing, 00:01:19.634 -- 00:01:23.140 collaborations, and other strategic partnerships. 00:01:23.140 -- 00:01:28.649 The potential for our clinical trials to be registra...